---

Gert Riethmueller

Professor Emeritus of Immunology, Ludwig-Maximillian University of Munich

Gert is a prolific researcher with a strong interest in autoimmune diseases and cancer. He is considered a pioneer in tumor immunology and was one of the first to introduce monoclonal antibodies and immune cells into medical practice. In 1994, he published a landmark clinical study in The Lancet on the treatment of metastatic colon carcinoma, which led to the approval of the world’s first monoclonal cancer antibody (17-1A).

---

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016